TY - JOUR
T1 - Navigating the Path of Progress
T2 - the OMERACT 2023 Emerging Leaders Program
AU - Campbell, T Mark
AU - Finzel, Stephanie
AU - Siddle, Heidi
AU - Christensen, Robin
AU - Nielsen, Sabrina Mai
AU - Najm, Aurelie
AU - Otobo, Tarimobo M.
AU - Sahbudin, Ilfita
AU - Sinnathurai, Premarani
AU - Stok, Kathryn S.
AU - Touma, Zahi
AU - April, Karine Toupin
AU - Grosskleg, Shawna
AU - Tugwell, Peter
AU - Richards, Bethan
N1 - Copyright © 2024. Published by Elsevier Inc.
PY - 2024/2/21
Y1 - 2024/2/21
N2 - OBJECTIVES: The Outcome Measures in Rheumatology Clinical Trials (OMERACT) Emerging Leaders Program (ELP) aims to cultivate a cohort of skilled leaders within the OMERACT community empowering them with expertise and knowledge to help shape and steer the organization into the future. This publication highlights the significance of the ELP in driving leadership excellence, its impact on OMERACT's evolution, and the outcomes and learnings from the OMERACT 2023 ELP.METHODS: Insights from the 2018 ELP report informed 2023 program improvements. Engagement was measured by attendance and WhatsApp interactions. Positive program aspects, areas for improvement and ideas for enhancing future ELPs were captured via anonymous survey and participant focus groups.RESULTS: Engagement with the ELP was high with 9 participants, 96 % attendance at all workshops, 154 WhatsApp interactions. All program components were highly rated, with the highest being the 'Psychological Safety' and 'Methodology/Process/Politics' workshops. Future enhancements included creating further networking, connection and support activities, practical leadership and methodological skill development opportunities, and a new stream focussing on organisational advancement.CONCLUSIONS: The 2023 OMERACT ELP was well received and successfully addressed areas previously identified as requiring improvement. New educational enhancements were valued, and the importance of fostering psychological safety at all levels was highlighted. The ELP fortifies OMERACT by nurturing a diverse array of skilled leaders who embody OMERACTs core values. Continuing to refine and evolve the ELP over time will help OMERACT sustain its global influence in patient-centered outcome research.
AB - OBJECTIVES: The Outcome Measures in Rheumatology Clinical Trials (OMERACT) Emerging Leaders Program (ELP) aims to cultivate a cohort of skilled leaders within the OMERACT community empowering them with expertise and knowledge to help shape and steer the organization into the future. This publication highlights the significance of the ELP in driving leadership excellence, its impact on OMERACT's evolution, and the outcomes and learnings from the OMERACT 2023 ELP.METHODS: Insights from the 2018 ELP report informed 2023 program improvements. Engagement was measured by attendance and WhatsApp interactions. Positive program aspects, areas for improvement and ideas for enhancing future ELPs were captured via anonymous survey and participant focus groups.RESULTS: Engagement with the ELP was high with 9 participants, 96 % attendance at all workshops, 154 WhatsApp interactions. All program components were highly rated, with the highest being the 'Psychological Safety' and 'Methodology/Process/Politics' workshops. Future enhancements included creating further networking, connection and support activities, practical leadership and methodological skill development opportunities, and a new stream focussing on organisational advancement.CONCLUSIONS: The 2023 OMERACT ELP was well received and successfully addressed areas previously identified as requiring improvement. New educational enhancements were valued, and the importance of fostering psychological safety at all levels was highlighted. The ELP fortifies OMERACT by nurturing a diverse array of skilled leaders who embody OMERACTs core values. Continuing to refine and evolve the ELP over time will help OMERACT sustain its global influence in patient-centered outcome research.
KW - OMERACT
KW - Education
KW - Emerging Leaders
KW - Career Development
KW - Core Outcome Set
KW - Early Career Researchers
U2 - 10.1016/j.semarthrit.2024.152414
DO - 10.1016/j.semarthrit.2024.152414
M3 - Article
C2 - 38447468
SN - 0049-0172
VL - 66
JO - Seminars in arthritis and rheumatism
JF - Seminars in arthritis and rheumatism
M1 - 152414
ER -